Trinity Capital Provides $15MM in Growth Capital to Cagent Vascular
Trinity Capital, an alternative asset manager, committed $15 million in growth capital to Cagent Vascular, a developer of serration technology for vessel dilation in endovascular interventions. This capital augments $45 million of equity financing led by US Venture Partners in...
Read moreDetails










